Item 15. Exhibits and Financial Statement Schedules

(a)The following documents are filed as part of this Form 10-K:

(1)Financial Statements

The following documents are included as Part II, Item 8 of this Form 10-K:


			Page
Report of Independent Registered Public Accounting Firm (KPMG LLP, Santa Clara, CA, PCAOB ID: 185)			50
Consolidated Balance Sheets			52
Consolidated Statements of Income			53
Consolidated Statements of Comprehensive Income			54
Consolidated Statements of Stockholders’ Equity			55
Consolidated Statements of Cash Flows			56
Notes to Consolidated Financial Statements			57

(2)Financial Statement Schedules

Schedules not listed above have been omitted because the information required to be set forth therein is not applicable or is shown in the financial statements or notes herein.

(3)Exhibits

See Item 15(b) below.

(b)Exhibits

EXHIBIT INDEX


Exhibit Number	Exhibit Description		Incorporated By Reference						Filed or Furnished Herewith
Form		File No.		Exhibit		Filing Date
3.1	Amended and Restated Certificate of Incorporation		10-Q		000-19807		3.1	9/15/2003
3.2	Amended and Restated Bylaws		10-K		000-19807		3.2	12/15/2020
4.1	Description of Synopsys' Capital Stock		10-K		000-19807		4.2	12/15/2020
10.1	Fifth Extension and Amendment Agreement, dated December 14, 2022, among Synopsys as Borrower, the Lenders parties thereto and JPMorgan Chase Bank, N.A., as administrative agent for the lenders.		8-K		000-19807		10.1	12/14/2022
10.2*	2006 Employee Equity Incentive Plan, as amended		8-K		000-19807		10.2	4/14/2023
10.3*	Form of Restricted Stock Unit Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan		8-K		000-19807		10.3	4/14/2023

Table of Contents


Exhibit Number	Exhibit Description		Incorporated By Reference						Filed or Furnished Herewith
Form		File No.		Exhibit		Filing Date
10.4*	Form of Stock Option Grant Notice and Award Agreement under 2006 Employee Equity Incentive Plan		8-K		000-19807		10.4	4/14/2023
10.5*	Employee Stock Purchase Plan, as amended		8-K		000-19807		10.6	4/15/2022
10.6*	2017 Non-Employee Directors Equity Incentive Plan		8-K		000-19807		10.8	4/10/2017
10.7*	Form of Restricted Stock Grant Notice and Award Agreement under 2017 Non-Employee Directors Equity Incentive Plan		10-K		000-19807		10.9	12/14/2017
10.8*	Form of Stock Options Grant Notice and Option Agreement under 2017 Non-Employee Directors Equity Incentive Plan		10-K		000-19807		10.10	12/14/2017
10.9*	Deferred Compensation Plan as restated effective August 1, 2002		10-Q		000-19807		10.5	6/10/2004
10.10*	Synopsys Amended and Restated Deferred Compensation Plan II		10-Q		000-19807		10.23	3/9/2009
10.11	Form of Indemnification Agreement for directors and executive officers		8-K		000-19807		99.2	7/14/2011
10.12*	Director’s and Officer’s Insurance and Company Reimbursement Policy		S-1		33-45138		10.2	2/24/1992 (effective date)
10.13*	Amended and Restated Employment Agreement, dated December 15, 2016 between Synopsys, Inc. and Dr. Aart de Geus		8-K		000-19807		10.16	12/21/2016
10.14*	Executive Incentive Plan, as amended		10-Q		000-19807		10.1	2/17/2023
10.15*	Amended and Restated Executive Change of Control Severance Benefit Plan		8-K		000-19807		10.19	12/21/2016
10.16*	Executive Severance Benefit and Transition Plan		8-K		000-19807		10.1	2/9/2021
10.17*	Relocation Assistance Agreement, dated April 30, 2021, by and between Synopsys, Inc. and Sassine Ghazi		10-Q		000-19807		10.2	5/21/2021
10.18*	Offer Letter, dated November 23, 2022, by and between Synopsys, Inc. and Shelagh Glaser		8-K		000-19807		10.1	11/29/2022
21.1	Subsidiaries of Synopsys, Inc.								X

Table of Contents


Exhibit Number	Exhibit Description		Incorporated By Reference			Filed or Furnished Herewith
Form		File No.		Exhibit	Filing Date
23.1	Consent of KPMG LLP, Independent Registered Public Accounting Firm					X
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act					X
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act					X
32.1+	Certification of Chief Executive Officer and Chief Financial Officer furnished pursuant to Rule 13a-14(b) or Rule 15d-14(b) of the Exchange Act and Section 1350 of Chapter 63 of Title 18 of the United States Code					X
97.1	Compensation Recovery Policy					X
101	The following financial statements from the Company’s Annual Report on Form 10-K for the year ended October 28, 2023, formatted in Inline XBRL: (i) Consolidated Balance Sheets as of October 28, 2023 and October 29, 2022, (ii) Consolidated Statements of Income for the Years Ended October 28, 2023, October 29, 2022 and October 30, 2021 (iii) Consolidated Statements of Comprehensive Income for the Years Ended October 28, 2023, October 29, 2022 and October 30, 2021 (iv) Consolidated Statements of Stockholders' Equity for the Years Ended October 28, 2023, October 29, 2022 and October 30, 2021 , (v) Consolidated Statements of Cash Flows for the Years Ended October 28, 2023, October 29, 2022 and October 30, 2021 (vi) Notes to Consolidated Financial Statements, tagged as blocks of text and including detailed tags					X

Indicates a management contract, compensatory plan or arrangement.

+ This exhibit is furnished with this Annual Report on Form 10-K and is not deemed filed with the Securities and Exchange Commission and is not incorporated by reference in any filing of Synopsys, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language contained in such filing.

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		SYNOPSYS, INC.

Date: December 12, 2023	By:	/s/ SHELAGH GLASER
		Shelagh Glaser Chief Financial Officer (Principal Financial Officer)

Table of Contents

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:


Name	Title	Date

/S/ AART J. DE GEUS	Chief Executive Officer (Principal Executive Officer) and Chair of the Board of Directors	December 12, 2023
Aart J. de Geus

/S/ SHELAGH GLASER	Chief Financial Officer (Principal Financial Officer)	December 12, 2023
Shelagh Glaser

/S/ SUDHINDRA KANKANWADI	Chief Accounting Officer (Principal Accounting Officer)	December 12, 2023
Sudhindra Kankanwadi

/S/ SASSINE GHAZI	President, Chief Operating Officer and Director	December 12, 2023
Sassine Ghazi

/S/ LUIS BORGEN	Director	December 12, 2023
Luis Borgen

/S/ MARC CASPER	Director	December 12, 2023
Marc Casper

/S/ JANICE D. CHAFFIN	Director	December 12, 2023
Janice D. Chaffin

/S/ BRUCE R. CHIZEN	Director	December 12, 2023
Bruce R. Chizen

/S/ MERCEDES JOHNSON	Director	December 12, 2023
Mercedes Johnson

/S/ ROBERT PAINTER	Director	December 12, 2023
Robert Painter

/s/ JEANNINE SARGENT	Director	December 12, 2023
Jeannine Sargent

/S/ JOHN G. SCHWARZ	Director	December 12, 2023
John G. Schwarz

/S/ ROY VALLEE	Director	December 12, 2023
Roy Vallee

Previous: Item 14. Principal Accountant Fees and Services